Showing results (1-10 of 478) with videos related to

Sort By:
Pageof 48
Pharmacoeconomics|August 18, 2000
Evaluating the potential 'economic attractiveness' of new therapies in patients with non-ST elevation acute coronary syndromeE L Eisenstein, E D Peterson, J G Jollis, et al.
Proceedings : a Conference of the American Medical Informatics Association. AMIA Fall Symposium|January 1, 1997
Assessing the value of newer pharmacologic agents in non-ST elevation patients: a decision support system applicationE L Eisenstein, E D Peterson, J G Jollis, et al.
European Heart Journal|February 3, 1998
The GUSTO trial and the open artery theoryR M Califf
The American Journal of Cardiology|November 11, 1998
A perspective on the regulation of the evaluation of new antithrombotic drugsR M Califf
Journal of Internal Medicine|October 11, 2003
Issues facing clinical trials of the futureR M Califf
American Heart Journal|January 29, 2000
Combination therapy for acute myocardial infarction: fibrinolytic therapy and glycoprotein IIb/IIIa inhibitionR M Califf
American Heart Journal|July 1, 1999
Glycoprotein IIb/IIIa blockade and thrombolytics: early lessons from the SPEED and GUSTO IV trialsR M Califf
European Heart Journal|September 1, 1996
The rationale for thrombolytic therapyR M Califf
Cardiology Clinics|August 1, 1995
How should clinicians interpret clinical trials?R M Califf
American Heart Journal|September 1, 1995
Restenosis: the cost to societyR M Califf
Pageof 48